Albumin

Albumins unique properties offer unlimited potential in the field of medical science.

Learn more
TEST TEST

Products

Learn more about our Recombumin® portfolio of recombinant human albumin products.

Show me

Applications

Our albumins enable the effective formulation of otherwise hard-to-stabilize drug, vaccine and cell therapies.

Read more

Pipeline

Albumedix has established a strong portfolio of valued partnerships.

Check it out

WHAT MAKES ALBUMEDIX THE PARTNER OF CHOICE?

cGMP Manufacturing

Batch-to-Batch Consistency

Regulatory Support

High Quality Products

Technical Support

Consistent Supply

NEWS & EVENTS

Let’s talk about company culture in self-isolation

Amidst the uncertainty and stress of this unprecedented time, it’s easy to feel a dip in morale. No longer being able to nip for a cup of tea with colleagues or have a lunchtime catch up in one of our busy kitchen areas, a sub-team within Albumedix formed to capture ideas that would protect our extremely supportive company culture.

Read more
Recombumin® Application Areas

Albumedix range of recombinant human albumins (the Recombumin® product portfolio) can be used across a range of application areas. Learn more about each here.

Read more
Improving Stability of Cells – An Alternative to Complex Logistics for Cell Therapies

The cell and gene therapy industry has, over the past years, proven its potential and many patients are now benefitting from advanced therapies with dramatic clinical results. Increasing clinical activity in diverse and more prevalent indications is prompting considerable effort and progress in addressing various manufacturing and logistical challenges in order to make more practical and scalable therapies.

Read more
Supporting Chalice Medical in their efforts to save lives

One of our valued medical device partners in the UK, Chalice Medical, is working around the clock to handle the huge surge in demand of their ECMO devices (oxygenators / life support machines). This surge has come as a result of the Covid-19 pandemic. In response, Albumedix is doing all we can to prioritize their shipments and any others related to the outbreak of the virus.

Read more
CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs

Albumedix, the world leader in recombinant human albumin, announced today that the Center for Biologics Evaluation and Research (CBER), one of six main centers for the U.S. Food and Drug Administration (FDA), has accepted a Drug Master File (DMF) submission for the company’s Recombumin® Elite.

Read more
CORONAVIRUS PREPAREDNESS AND BUSINESS CONTINUITY STATEMENT

As a global provider of recombinant human albumin for the life science industry, Albumedix are fully dedicated to ensuring a stable product supply to our customers in all regions of the world. As such, we are actively monitoring and responding to the potential impact of the Coronavirus disease (COVID-19) outbreak.

Read more
'A day in the life of Matt' - Director of Manufacturing Operations

Albumedix is a world leading manufacturer of recombinant human albumin (rHA), and as such our manufacturing plant is the core of our business. As a company, we talk a lot about our rHA products, how they’re useful in different applications and what benefits they can bring to final therapies for patients worldwide. However, we don’t talk as much about the amazing people within our business that make the magic happen.

Read more
Back from Cell Therapy Manufacturing ASIA - Thoughts from our Director of Market Development

As a key excipient/raw material supplier, Albumedix monitors advancements, innovation, trends and conversations in the cell therapy manufacturing industry closely. This is why at the end of February, our Director of Market Development and Communication (Poula Maltha Krogh) attended the Cell Therapy Manufacturing ASIA conference in Kyoto.

Read more
Raising the Standards of Pharmaceutical Excipients – Back from the IPEC Forum

Albumedix attended the International Pharmaceutical Excipients Council (IPEC) Annual Forum and AGM in Aix-en-Provence, France earlier this month.

Read more
What cell and gene therapy trends will we all be talking about in 2020?

Back from Phacilitate conference in Miami, we reflect on the exciting trends and developments presented and cannot wait for what 2020 will bring!

Read more
Albumin: From Peptides, to Proteins, to Viral Vectors

Albumedix has attended PepTalk for many years, and as the world of biopharmaceuticals expands towards more complex entities, albumin will always play a role in the stabilisation of the most challenging APIs. As an example of albumin’s potential in stabilising difficult biopharmaceuticals, we have presented the results obtained for glucagon , a notoriously insoluble and unstable peptide. Albumin was not only able to allow the solubilisation of this APIs in a close-to-physiological conditions, where the peptide is insoluble, but also protected it from chemical and physical degradation in accelerated stability tests.

Read more
Christmas 'Capping Off' Ceremony

In December, Albumedix held a 'Capping off Ceremony' to celebrate the brand new, four-storey manufacturing plant extension being confirmed as watertight!

Read more
Improving patient quality of life by leveraging our unique albumin-based products and technologies.
Dedicated to Better Health